Published in Clin Radiol on December 01, 2005
HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts. PLoS One (2011) 1.12
Functional imaging: CT and MRI. Clin Chest Med (2008) 0.96
Multidetector CT imaging of pleura: comparison of two contrast infusion protocols. Br J Radiol (2010) 0.81
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol (2005) 2.65
Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis. J Nucl Med (1990) 2.63
Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med (1996) 2.03
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med (1999) 1.95
A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med (1999) 1.67
Does reporting of plain chest radiographs affect the immediate management of patients admitted to a medical assessment unit? Clin Radiol (2003) 1.63
99Tcm sestamibi--a new agent for parathyroid imaging. Nucl Med Commun (1989) 1.63
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2000) 1.62
Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium. Eur J Nucl Med Mol Imaging (2003) 1.59
Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J (1991) 1.54
The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol (2006) 1.51
18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size. Eur J Nucl Med Mol Imaging (2014) 1.47
Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood (1998) 1.44
Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. Eur J Cancer (2012) 1.41
Gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (1994) 1.40
Secretion of [123I] iodide in breast milk following administration of [123I] meta-iodobenzylguanidine. Eur J Nucl Med (1994) 1.39
Is perfusion lung scanning hazardous in pulmonary hypertension? Nucl Med Commun (1995) 1.38
Cerebral perfusion deficits in divers with neurological decompression illness. Nucl Med Commun (1993) 1.38
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT. Leuk Lymphoma (2000) 1.34
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg (1999) 1.24
Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy (2005) 1.22
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer (2000) 1.16
Radionuclide parathyroid imaging. J Nucl Med (1997) 1.15
Dual energy X-ray absorptiometry normal reference range use within the UK and the effect of different normal ranges on the assessment of bone density. Br J Radiol (1995) 1.13
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br (1998) 1.12
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma. Ann Oncol (2010) 1.08
Letter to the editor re: positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imaging Biol (2013) 1.07
The value of the chest radiograph in reporting aerosol ventilation-perfusion scans. Nucl Med Commun (1998) 1.07
Radiation dose rates post 131I therapy and advice to patients on discharge from hospital. Health Phys (1997) 1.07
Radiation dose rates from patients undergoing PET: implications for technologists and waiting areas. Eur J Nucl Med (2000) 1.07
Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am Rev Respir Dis (1993) 1.06
(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med (2000) 1.06
Ultrasound guided cytological aspiration of supraclavicular lymph nodes in patients with suspected lung cancer. Thorax (2005) 1.03
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas. Ann Oncol (2000) 1.02
FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy. Eur J Nucl Med Mol Imaging (2002) 1.00
Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. Thorax (1991) 0.99
The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging (2004) 0.99
Regional lung epithelial leakiness in smokers and nonsmokers. Nucl Med Commun (1985) 0.96
Fatal Stevens-Johnson syndrome in a patient on captopril and allopurinol. Lancet (1984) 0.94
Variability in the measurement of nebulized aerosol deposition in man. Clin Sci (Lond) (1991) 0.92
Pulmonary deposition of a nebulised aerosol during mechanical ventilation. Thorax (1993) 0.92
Recurrent Strongyloides stercoralis infection in a patient with T-cell lymphoma-leukaemia. Lancet (1984) 0.92
[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg (2000) 0.91
Non-invasive management of fever and breathlessness in HIV positive patients. Eur Respir J (1991) 0.91
Lung 99Tcm-DTPA transfer: a method for background correction. Nucl Med Commun (1985) 0.91
Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer. Eur J Nucl Med (2001) 0.90
Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med (2000) 0.90
Indications for thoracic ultrasound in chest medicine: an observational study. Postgrad Med J (2010) 0.89
Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med (2000) 0.89
The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma. J Am Acad Dermatol (2000) 0.89
Image-guided pleural biopsy: diagnostic yield and complications. Clin Radiol (2006) 0.88
FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy. Eur J Nucl Med (2001) 0.88
2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Ann Oncol (2000) 0.88
Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg (1999) 0.87
Ventilation perfusion imaging--again. Nucl Med Commun (1992) 0.86
Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med (1998) 0.86
Folic acid absorption in patients infected with the human immunodeficiency virus. J Intern Med (1991) 0.85
The challenges of integrating molecular imaging into the optimization of cancer therapy. Integr Biol (Camb) (2011) 0.85
Solid phase synthesis of [18F]labelled peptides for positron emission tomography. Bioorg Med Chem Lett (2000) 0.85
Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation. Thorax (1995) 0.84
Ulcerative colitis developing after amoebic dysentery in a haemophiliac patient with AIDS. Gut (1992) 0.83
Exposure of critical groups to nuclear medicine patients. Appl Radiat Isot (1999) 0.83
Pentavalent 99Tcm-DMSA imaging in patients with bone metastases. Nucl Med Commun (1997) 0.83
Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours? Nucl Med Commun (2003) 0.83
Hepatitis A vaccine responses in HIV-positive persons with haemophilia. Vaccine (1996) 0.82
Therapeutic aerosols in children. BMJ (1993) 0.82
Diabetes and bone: advantages and limitations of radiological, radionuclide and hybrid techniques in the assessment of diabetic foot. Minerva Endocrinol (2009) 0.82
The importance of ultrasound in staging and gaining a pathological diagnosis in patients with lung cancer--a two year single centre experience. Thorax (2011) 0.81
Multidetector CT imaging of pleura: comparison of two contrast infusion protocols. Br J Radiol (2010) 0.81
Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy. Clin Immunol (2009) 0.81
In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection. Eur J Nucl Med (2001) 0.80
The early use of PET-CT alters the management of patients with esophageal cancer. J Gastrointest Surg (2009) 0.80
Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J (1997) 0.79
Pulmonary permeability in hematologic malignancies. Effects of the disease and cytotoxic agents. Cancer (1986) 0.79
Differentiated thyroid cancer and pregnancy. Nucl Med Commun (2000) 0.79
Iodine-123 salmon calcitonin, an imaging agent for calcitonin receptors: synthesis, biodistribution, metabolism and dosimetry in humans. Eur J Nucl Med (1998) 0.79
Positron emission tomography and the orthopaedic surgeon. J Bone Joint Surg Br (2000) 0.79
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Eur J Nucl Med (1998) 0.79
Dose rate measurements combined with social behavior models enables estimation of potential radiation hazards to families of patients treated with radioiodine. Health Phys (2000) 0.78
Management benefits and safety of computed tomography in patients undergoing extracorporeal membrane oxygenation therapy: experience of a single centre. Clin Radiol (2010) 0.78
Disposition of intravenous 123iodopentamidine in man. Nucl Med Biol (1997) 0.78
The effects of standardization and reference values on patient classification for spine and femur dual-energy X-ray absorptiometry. Osteoporos Int (1997) 0.78
Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism. Eur J Nucl Med Mol Imaging (2008) 0.78
99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med (2000) 0.77
Brain biopsy for intracranial mass lesions in AIDS. Lancet (1993) 0.77
Pulmonary nuclear medicine. Eur J Nucl Med (1992) 0.77
99mTc-SnF2 colloid "LLK": particle size, morphology and leucocyte labelling behaviour. Nucl Med Commun (2003) 0.77
Spiral CT pneumocolon for suspected colonic neoplasms. Clin Radiol (1996) 0.77
Streptococcus milleri infection of a hepatopulmonary hydatid cyst. Eur J Clin Microbiol (1987) 0.77
A survey of dual-energy X-ray absorptiometry (DEXA) normal reference ranges used within the UK and their effect on patient classification. Nucl Med Commun (1995) 0.77
123I-methylene blue: an unsatisfactory parathyroid imaging agent. Nucl Med Commun (1992) 0.76
Treating thyrotoxicosis in pregnant or potentially pregnant women. BMJ (1999) 0.76
Quantification of technetium-99m lung radioactivity from planar images. Eur J Nucl Med (1993) 0.76
Clinical PET in the UK: dangers of missing an opportunity. Nucl Med Commun (2001) 0.75
Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS. Thorax (1992) 0.75
Patient guidance after 131I therapy. Lancet (1992) 0.75
Bone mineral densitometry in clinical practice. Differences in reference values are important. BMJ (1995) 0.75
Aerosol deposition in mechanically ventilated patients. Am J Respir Crit Care Med (1994) 0.75
The value of performing head CT in screening for cerebral metastases in patients with potentially resectable non-small cell lung cancer: experience from a UK cardiothoracic centre. Clin Radiol (2005) 0.75
A myocardial perfusion imaging service: how are we to meet the challenge? Nucl Med Commun (2003) 0.75